Diagnosis of Multisystem Inflammatory Syndrome in Child (MIS-C) Case Presenting with Acute Dystonia Secondary to Use of Metoclopramide

Öz

Metoclopramide is a dopamine antagonist in the central nervous system and an antiemetic agent. It can cause extrapyramidal symptoms side effects such as dystonic reactions characterized by involuntary, sustained or spasmodic contractions of muscle groups, resulting in twisting, repetitive or abnormal postures. In this study, we aimed to report a pediatric patient who presented with acute dystonia due to metoclopramide use and was finally diagnosed with MIS-C.

Anahtar Kelimeler

• Acute dystonia
• metoclopramide
• multisystem inflammatory syndrome in child

Proje Numarası

yok

Kaynakça

1. Lau Moon Lin M, Robinson PD, Flank J, Sung L, Dupuis LL. The Safety of Metoclopramide in Children: A Systematic Review and Meta-Analysis. Drug Saf. 2016;39(7):675-87.
2. Dingli K, Morgan R, Leen C. Acute dystonic reaction caused by metoclopramide, versus tetanus. BMJ. 2007;334(7599):899-900.
3. Yis U, Ozdemir D, Duman M, Unal N. Metoclopramide induced dystonia in children: two case reports. Eur J Emerg Med. 2005;12(3):117-9.
4. Kofman AD, Sizemore EK, Detelich JF, Albrecht B, Piantadosi AL. A young adult with COVID-19 and multisystem inflammatory syndrome in children (MIS-C)-like illness: a case report. BMC Infect Dis. 2020;20(1):716.
5. Aldawas A, Ishfaq M. COVID-19: Multisystem Inflammatory Syndrome in Children (MIS-C). Cureus. 2022;14(1):e21064.
6. Çiçek G, Ayaz İO, Ünal I, Önal Ö, Arıcı T, Yücel B, et al. Could COVID‐19 cause loss of spermmotility? Cukurova Med J. 2021;46(2):858-60.
7. Tianyi FL, Agbor VN, Njim T. Metoclopramide induced acute dystonic reaction: a case report. BMC Research Notes. 2017;10(1):32.
8. Lewis K, O'Day CS. Dystonic Reactions. StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.

9. Boran ÖF, Büyükfırat E, Elibol FE, Dolu H, Dalyan MA, Karadağ S. Biperiden intoksikasyonunda fizostigmin kullanımı: olgu sunumu. KSU Tıp Fak Der. 2016;11(1):20-1.
10. Bentes AA, Dos Santos Junior WR, Pessoa NL, Costa TA, Oliveira GFG, Diniz LMO, et al. Neuro-COVID-19 with or without the multisystem inflammatory syndrome (MIS-C): a single-center study : COVID-19: neurologic manifestations in children. J Mol Neurosci. 2023:1-9.
11. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607-8.
12. Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094.
13. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19): The CDC Health Alert Network. 2020 [16.06.2022]. Available from: https://emergency.cdc.gov/han/2020/han00432.asp.
14. Multisystem inflammatory syndrome in children and adolescents with COVID-19 World Health Organization (WHO). 2020; [22.06.2022]. Available from: https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19.
15. Mahmoud S, El-Kalliny M, Kotby A, El-Ganzoury M, Fouda E, Ibrahim H. Treatment of MIS-C in children and adolescents. Curr Pediatr Rep. 2022;10(1):1-10.